277 MYLAN (Amitriptyline and chlordiazepoxide 25 mg / 10 mg)
Pill imprint 277 MYLAN has been identified as Amitriptyline and chlordiazepoxide 25 mg / 10 mg.
Amitriptyline/chlordiazepoxide is used in the treatment of anxiety; depression and belongs to the drug class psychotherapeutic combinations. FDA has not classified the drug for risk during pregnancy. Amitriptyline/chlordiazepoxide 25 mg / 10 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- 277 MYLAN
- 25 mg / 10 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Psychotherapeutic combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|16590-0800||Stat RX USA LLC (repackager)|
More about amitriptyline/chlordiazepoxide
- Side Effects
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 8 Reviews – Add your own review/rating
- Drug class: psychotherapeutic combinations
- Amitriptyline and chlordiazepoxide
- Chlordiazepoxide and amitriptyline (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.